Europe Cancer Immunotherapy Market Research Report Forecast 2017-2021

September 2017 | 103 pages | ID: E8F759C114FEN
S&P Consulting

Abstracts

The Europe Cancer Immunotherapy Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cancer Immunotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Immunotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Cancer Immunotherapy Market Analysis by Countries :
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis

Europe Cancer Immunotherapy Market Analysis by Product :
Type 1
Type 2
Type 3

Europe Cancer Immunotherapy Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 CANCER IMMUNOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Classification of Cancer Immunotherapy
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cancer Immunotherapy
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Immunotherapy Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Cancer Immunotherapy (2012-2021)
  1.5.1 Europe Cancer Immunotherapy Sales and Growth Rate (2012-2021)
  1.5.2 Europe Cancer Immunotherapy Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON CANCER IMMUNOTHERAPY INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

3.1 Cancer Immunotherapy Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cancer Immunotherapy

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cancer Immunotherapy Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE CANCER IMMUNOTHERAPY MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Cancer Immunotherapy Market Competition by Manufacturers
  5.1.1 Europe Cancer Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Cancer Immunotherapy (Volume and Value) by Type
  5.2.1 Europe Cancer Immunotherapy Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
5.3 Europe Cancer Immunotherapy (Volume and Value) by Countries
  5.3.1 Europe Cancer Immunotherapy Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Cancer Immunotherapy Revenue and Market Share by Countries (2012-2017)
5.4 Europe Cancer Immunotherapy (Volume) by Application

6 GERMANY CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Cancer Immunotherapy Sales and Value (2012-2017)
  6.1.1 Germany Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  6.1.2 Germany Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Cancer Immunotherapy Sales Price Trend (2012-2017)
6.2 Germany Cancer Immunotherapy Sales and Market Share by Manufacturers
6.3 Germany Cancer Immunotherapy Sales and Market Share by Type
6.4 Germany Cancer Immunotherapy Sales and Market Share by Application

7 FRANCE CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 France Cancer Immunotherapy Sales and Value (2012-2017)
  7.1.1 France Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  7.1.2 France Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  7.1.3 France Cancer Immunotherapy Sales Price Trend (2012-2017)
7.2 France Cancer Immunotherapy Sales and Market Share by Manufacturers
7.3 France Cancer Immunotherapy Sales and Market Share by Type
7.4 France Cancer Immunotherapy Sales and Market Share by Application

8 UK CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 UK Cancer Immunotherapy Sales and Value (2012-2017)
  8.1.1 UK Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  8.1.2 UK Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  8.1.3 UK Cancer Immunotherapy Sales Price Trend (2012-2017)
8.2 UK Cancer Immunotherapy Sales and Market Share by Manufacturers
8.3 UK Cancer Immunotherapy Sales and Market Share by Type
8.4 UK Cancer Immunotherapy Sales and Market Share by Application

9 RUSSIA CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Cancer Immunotherapy Sales and Value (2012-2017)
  9.1.1 Russia Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  9.1.2 Russia Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Cancer Immunotherapy Sales Price Trend (2012-2017)
9.2 Russia Cancer Immunotherapy Sales and Market Share by Manufacturers
9.3 Russia Cancer Immunotherapy Sales and Market Share by Type
9.4 Russia Cancer Immunotherapy Sales and Market Share by Application

10 ITALY CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Cancer Immunotherapy Sales and Value (2012-2017)
  10.1.1 Italy Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  10.1.2 Italy Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Cancer Immunotherapy Sales Price Trend (2012-2017)
10.2 Italy Cancer Immunotherapy Sales and Market Share by Manufacturers
10.3 Italy Cancer Immunotherapy Sales and Market Share by Type
10.4 Italy Cancer Immunotherapy Sales and Market Share by Application

11 SPAIN CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Cancer Immunotherapy Sales and Value (2012-2017)
  11.1.1 Spain Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  11.1.2 Spain Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Cancer Immunotherapy Sales Price Trend (2012-2017)
11.2 Spain Cancer Immunotherapy Sales and Market Share by Manufacturers
11.3 Spain Cancer Immunotherapy Sales and Market Share by Type
11.4 Spain Cancer Immunotherapy Sales and Market Share by Application

12 BENELUX CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Cancer Immunotherapy Sales and Value (2012-2017)
  12.1.1 Benelux Cancer Immunotherapy Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Cancer Immunotherapy Sales Price Trend (2012-2017)
12.2 Benelux Cancer Immunotherapy Sales and Market Share by Manufacturers
12.3 Benelux Cancer Immunotherapy Sales and Market Share by Type
12.4 Benelux Cancer Immunotherapy Sales and Market Share by Application

13 EUROPE CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS

13.1 Amgen
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 AstraZeneca
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 F. Hoffman La-Roche
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Bayer AG
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Bristol-Myers Squibb
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Eli Lilly and Company
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Janssen Global Services
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Merck
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Novartis
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE CANCER IMMUNOTHERAPY MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Cancer Immunotherapy Market Forecast by Type (2017-2021)
15.9 Europe Cancer Immunotherapy Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Immunotherapy
Table Classification of Cancer Immunotherapy
Figure Europe Sales Market Share of Cancer Immunotherapy by Type in 2015
Table Application of Cancer Immunotherapy
Figure Europe Sales Market Share of Cancer Immunotherapy by Application in 2015
Figure Germany Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure France Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure UK Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Spain Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Benelux Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Figure Europe Cancer Immunotherapy Sales and Growth Rate (2012-2021)
Figure Europe Cancer Immunotherapy Revenue and Growth Rate (2012-2021)
Table Europe Cancer Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Sales Share by Manufacturers
Figure 2016 Cancer Immunotherapy Sales Share by Manufacturers
Table Europe Cancer Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 Europe Cancer Immunotherapy Revenue Share by Manufacturers
Table Europe Cancer Immunotherapy Sales and Market Share by Type (2012-2017)
Table Europe Cancer Immunotherapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Immunotherapy by Type (2012-2017)
Figure Europe Cancer Immunotherapy Sales Growth Rate by Type (2012-2017)
Table Europe Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
Table Europe Cancer Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Immunotherapy by Type (2012-2017)
Figure Europe Cancer Immunotherapy Revenue Growth Rate by Type (2012-2017)
Table Europe Cancer Immunotherapy Sales and Market Share by Countries (2012-2017)
Table Europe Cancer Immunotherapy Sales Share by Countries (2012-2017)
Figure Sales Market Share of Cancer Immunotherapy by Countries (2012-2017)
Table Europe Cancer Immunotherapy Revenue and Market Share by Countries (2012-2017)
Table Europe Cancer Immunotherapy Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Cancer Immunotherapy by Countries (2012-2017)
Table Europe Cancer Immunotherapy Sales and Market Share by Application (2012-2017)
Table Europe Cancer Immunotherapy Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Immunotherapy by Application (2012-2017)
Figure Germany Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Germany Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Germany Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Germany Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Germany Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Germany Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Germany Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure France Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure France Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure France Cancer Immunotherapy Sales Price Trend (2012-2017)
Table France Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table France Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table France Cancer Immunotherapy Sales by Type (2015 and 2016)
Table France Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table France Cancer Immunotherapy Sales by Application (2015 and 2016)
Table France Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure UK Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure UK Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure UK Cancer Immunotherapy Sales Price Trend (2012-2017)
Table UK Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table UK Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Immunotherapy Sales by Type (2015 and 2016)
Table UK Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table UK Cancer Immunotherapy Sales by Application (2015 and 2016)
Table UK Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Russia Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Russia Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Russia Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Russia Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Russia Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Russia Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Italy Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Italy Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Italy Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Italy Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Italy Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Italy Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Spain Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Spain Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Spain Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Spain Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Spain Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Spain Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Spain Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Benelux Cancer Immunotherapy Sales and Growth Rate (2012-2017)
Figure Benelux Cancer Immunotherapy Revenue and Growth Rate (2012-2017)
Figure Benelux Cancer Immunotherapy Sales Price Trend (2012-2017)
Table Benelux Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Benelux Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Benelux Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Benelux Cancer Immunotherapy Market Share by Application (2015 and 2016)
Table Amgen Basic Information List
Table Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Immunotherapy Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Immunotherapy Sales Market Share (2012-2017)
Table F. Hoffman La-Roche Basic Information List
Table F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffman La-Roche Cancer Immunotherapy Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Cancer Immunotherapy Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Immunotherapy Sales Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Cancer Immunotherapy Sales Market Share (2012-2017)
Table Janssen Global Services Basic Information List
Table Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Global Services Cancer Immunotherapy Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Immunotherapy Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Cancer Immunotherapy Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure Germany Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure Germany Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Figure France Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure France Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Figure UK Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure UK Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure Spain Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Cancer Immunotherapy Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Table Europe Cancer Immunotherapy Sales Forecast by Type (2017-2021)
Table Europe Cancer Immunotherapy Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
Pfizer
Seattle Genetics
Peregrine Pharmaceuticals
Viralytics Ltd
Immunomedics